Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Autoimmune Disorders

Free Subscription 15.12.2025 1 Ann Neurol 1 BMC Neurol 2 Brain 1 Curr Opin Immunol 5 Diabet Med 2 Intern Med 1 J Autoimmun 1 J Clin Endocrinol Metab 11 J Neuroimmunol 2 J Neurol 2 J Pediatr 2 Lancet Neurol 4 Mult Scler 1 N Engl J Med 1 PLoS Med 6 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. WAEDE M, Kingo C, Damsbo K, Joergensen MU, et al
   Phenotypic Changes in a Monocyte Cluster with High Interleukin-1 Beta Expression during Long-Term Anti-CD20 Therapy.
   Ann Neurol. 2025;98:1283-1298.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. GOTTBERG K, Kierkegaard M, Larsson BJ, Ytterberg C, et al
   Experiences of disease-modifying treatments in patients with multiple sclerosis - a qualitative study.
   BMC Neurol. 2025 Dec 10. doi: 10.1186/s12883-025-04576.
   PubMed         Abstract available
   
   

   
   Brain

3. BELLANTI R, Keh RYS, Keddie S, Chou MKL, et al
   Plasma periaxin is a biomarker of peripheral nerve demyelination.
   Brain. 2025;148:4448-4460.
   PubMed         Abstract available
   
   
4. BRUMMER T, Fleischer V
   Beyond clinical labels: a molecular-structural framework for multiple sclerosis subtyping.
   Brain. 2025;148:4155-4157.
   PubMed        
   
   

   
   Curr Opin Immunol

5. YANG T, Goudarzi N, Kroese FGM, Mariette X, et al
   Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjogren's disease.
   Curr Opin Immunol. 2025;98:102707.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. HABTE-ASRES HH, Stedman M, Forbes A, Karalliedde J, et al
   Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population-based study in Salford, Manchester.
   Diabet Med. 2025 Nov 20:e70175. doi: 10.1111/dme.70175.
   PubMed         Abstract available
   
   
7. ABILD CB, Vestergaard ET, Pauls DD, Bruun JM, et al
   Psychometric properties and factor structure of the diabetes eating problem survey revised in Danish adolescents with type 1 diabetes.
   Diabet Med. 2025 Nov 15:e70158. doi: 10.1111/dme.70158.
   PubMed         Abstract available
   
   
8. ERBASAN E, Aliciaslan M, Erendor F, Dandin O, et al
   Lantidra (donislecel) in type 1 diabetes: An in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy.
   Diabet Med. 2025 Nov 11:e70168. doi: 10.1111/dme.70168.
   PubMed         Abstract available
   
   
9. WONG JJ, Alamarie SA, Hanes SJ, Flores H, et al
   An RCT of a family intervention for adolescents living with type 1 diabetes: Who benefits most?
   Diabet Med. 2025 Oct 29:e70151. doi: 10.1111/dme.70151.
   PubMed         Abstract available
   
   
10. MANTOVANI M, Kwiendacz H, Irlik K, Bucci T, et al
    Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes-Heart Project.
    Diabet Med. 2025 Sep 18:e70136. doi: 10.1111/dme.70136.
    PubMed         Abstract available
    
    

    
    Intern Med

11. YAMAMOTO M, Dembo T, Yamaga T, Momose S, et al
    The Use of Vessel Wall Imaging for Making an Early Diagnosis of Giant Cell Arteritis in a Case with Cerebral Infarction.
    Intern Med. 2025 Dec 11. doi: 10.2169/internalmedicine.6532.
    PubMed         Abstract available
    
    
12. NAKANISHI Y, Watanabe H, Tsuyuki M, Kakumoto S, et al
    New-onset anti-melanoma differentiation-associated gene 5 antibody positive clinically amyopathic dermatomyositis following COVID-19: A case report.
    Intern Med. 2025 Dec 11. doi: 10.2169/internalmedicine.5163.
    PubMed         Abstract available
    
    

    
    J Autoimmun

13. NIELSEN HB, Gupta N, Andersen AJ, Dreyer LW, et al
    Physical work demands and risk of rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus. A Danish longitudinal cohort study.
    J Autoimmun. 2025;158:103514.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

14. WOLF J, Lorenz K, Othman AE, Beck A, et al
    Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
    J Clin Endocrinol Metab. 2025 Dec 9:dgaf655. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

15. CURTIS K, Hendry E, Christensen Z, Aidukaitis B, et al
    Longitudinally-extensive transverse myelitis in the setting of recent Mycoplasma infection: Case series.
    J Neuroimmunol. 2026;410:578785.
    PubMed         Abstract available
    
    
16. DEMPEGIOTI CA, Broumpoulis G, Brinia ME, Papadopoulos I, et al
    Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Balo's concentric sclerosis.
    J Neuroimmunol. 2026;410:578798.
    PubMed         Abstract available
    
    
17. MATSUYOSHI A, Shinoda K, Takeuchi H, Mizutani K, et al
    The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy.
    J Neuroimmunol. 2026;410:578799.
    PubMed         Abstract available
    
    
18. SECHI E, Gastaldi M, Cortese R, Bisecco A, et al
    Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management.
    J Neuroimmunol. 2026;410:578781.
    PubMed         Abstract available
    
    
19. LONG Q, Xie J, Yang Z, Zhang B, et al
    Personalized Ofatumumab therapy for autoimmune encephalitis: A case series of four patients.
    J Neuroimmunol. 2025;411:578835.
    PubMed         Abstract available
    
    
20. OREFICE NS, Amoriello R, Maghrebi O, Ballerini C, et al
    Early response in cytokine and miR-124a, -125b, -223 expression to anti-CD20 in Multiple Sclerosis and its animal model - a preliminary analysis.
    J Neuroimmunol. 2025;411:578823.
    PubMed         Abstract available
    
    
21. PALMER AL, Wang R, Zonta YR, Bailey ZDJ, et al
    Cytokine and chemokine production by astrocytes is influenced by Cystatin C.
    J Neuroimmunol. 2026;410:578801.
    PubMed         Abstract available
    
    
22. HE R, Zhong Z, Feng H, Yao X, et al
    Efficacy and safety of intravenous efgartigimod for chronic inflammatory demyelinating polyneuropathy: A case series real-world study.
    J Neuroimmunol. 2026;410:578796.
    PubMed         Abstract available
    
    
23. KWON YN, Ju W, Jeon JH, Hahm C, et al
    Clear-positive cut off determination of flow cytometric MOG-antibody assay in Korea: Alignment with international MOGAD diagnostic standards.
    J Neuroimmunol. 2026;410:578806.
    PubMed         Abstract available
    
    
24. RANIERI G, Chiarugi A, Buonvicino D
    Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis.
    J Neuroimmunol. 2026;410:578809.
    PubMed         Abstract available
    
    
25. BIANCO A, Russo R, Cicia A, Marini S, et al
    Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review.
    J Neuroimmunol. 2026;410:578808.
    PubMed         Abstract available
    
    

    
    J Neurol

26. BSTEH G, Velez Escola L, Hegen H, Lindner E, et al
    Application of optical coherence tomography in multiple sclerosis: consensus recommendations of the Austrian network (AN-OCT-MS).
    J Neurol. 2025;273:24.
    PubMed         Abstract available
    
    
27. TEDONE N, Preziosa P, Meani A, Mistri D, et al
    Clinical, functional and cognitive features of late-onset multiple sclerosis.
    J Neurol. 2025;273:14.
    PubMed         Abstract available
    
    

    
    J Pediatr

28. VALDIVIA CAMACHO OD, Allison T, Wilson LB, Bellsmith K, et al
    Pediatric Cataracts as a Presenting Sign of Type 1 Diabetes Mellitus.
    J Pediatr. 2025 Sep 11:114806. doi: 10.1016/j.jpeds.2025.114806.
    PubMed         Abstract available
    
    
29. ABEL D, Butler N, Chatterjee A, Tavlin S, et al
    A Qualitative Exploration of Adherence to Methotrexate in Juvenile Idiopathic Arthritis.
    J Pediatr. 2026;288:114798.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

30. DE CASTRO FONSECA M, Zanetti L, Fanourakis S, Sulzer DL, et al
    The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease.
    Lancet Neurol. 2026;25:103-114.
    PubMed         Abstract available
    
    
31. PITTOCK SJ
    Multiple sclerosis research in 2025: earlier diagnosis and halting progression.
    Lancet Neurol. 2026;25:20-22.
    PubMed        
    
    

    
    Mult Scler

32. GOMEZ-FIGUEROA E, Casallas-Vanegas A
    The revised 2024 McDonald diagnostic criteria can solve the misdiagnosis problem in multiple sclerosis: NO.
    Mult Scler. 2025 Dec 13:13524585251396290. doi: 10.1177/13524585251396290.
    PubMed        
    
    
33. RAMANATHAN S, Solomon AJ
    The revised 2024 McDonald criteria can solve the misdiagnosis problem in multiple sclerosis: YES.
    Mult Scler. 2025 Dec 13:13524585251396284. doi: 10.1177/13524585251396284.
    PubMed        
    
    
34. VAN DER WALT A
    'The revised 2024 McDonald criteria can solve the misdiagnosis problem in multiple sclerosis': Commentary.
    Mult Scler. 2025 Dec 13:13524585251396271. doi: 10.1177/13524585251396271.
    PubMed        
    
    
35. BSTEH G, Marti S, Hammer H, Krajnc N, et al
    Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?
    Mult Scler. 2025 Dec 6:13524585251396283. doi: 10.1177/13524585251396283.
    PubMed         Abstract available
    
    

    
    N Engl J Med

36. SCOTT J, Abers MS, Marwah HK, McCann NC, et al
    Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
    N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMsa2514268.
    PubMed         Abstract available
    
    

    
    PLoS Med

37. GONZALEZ-GAY MA, Gomez-Bernal F, Quevedo-Abeledo JC, Almeida-Santiago C, et al
    Ultrasensitive quantification of serum IFN-alpha and IFN-gamma in systemic lupus erythematosus: A cross-sectional observational study.
    PLoS Med. 2025;22:e1004841.
    PubMed         Abstract available
    
    

    
    PLoS One

38. LEE GM, Lee MJ, Kim N, Choung H, et al
    Photographic evaluation of clinical activity score in thyroid eye disease.
    PLoS One. 2025;20:e0337597.
    PubMed         Abstract available
    
    
39. KREITER D, Franken N, Bouweriks D, Knippenberg S, et al
    Spinal cord lesions in relapsing-remitting multiple sclerosis: Prognostic value of intrathecal production of immunoglobulins.
    PLoS One. 2025;20:e0337515.
    PubMed         Abstract available
    
    
40. DURON L, Chazal T, Sene T, Savatovsky J, et al
    Fast-track pathway for giant cell arteritis: Improved visual outcomes and reduced healthcare costs.
    PLoS One. 2025;20:e0338397.
    PubMed         Abstract available
    
    
41. VESTITO L, Schenone C, Casazza F, Modenesi R, et al
    Impact of anodal tDCS and virtual reality on cognitive dysfunction in patients with Multiple Sclerosis: Protocol of a double blind, randomized, prospective, controlled study.
    PLoS One. 2025;20:e0337405.
    PubMed         Abstract available
    
    
42. CHI G, Che Y, Pei J, Li X, et al
    Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing.
    PLoS One. 2025;20:e0335605.
    PubMed         Abstract available
    
    
43. LI Y, Liu B, Hu G, Zhou T, et al
    Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis.
    PLoS One. 2025;20:e0337060.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

44. JIA L, Liu M, Ji H, Lei J, et al
    Glomerular endothelial cells eliminate nicotinamide adenine dinucleotide to instruct CD103(+) T cells in human lupus nephritis.
    Proc Natl Acad Sci U S A. 2025;122:e2507422122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.